Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Lancet (London, England) | Added Aug 24, 2021

Should 18F-fluciclovine-PET/CT be included into the decision-making process for radiotherapy after surgery for prostate cancer?

This study evaluated the role of 18F-fluciclovine-PET-CT versus conventional imaging (bone scan and either CT or MRI) alone for salvage radiotherapy (RT) after prostate surgery for the treatment of patients with localized prostate cancer (PCa). The data showed that including 18F-fluciclovine-PET-CT into the decision-making process for RT after surgery significantly improved survival without recurrence for these patients.

icon
prostate cancer | Medivizor | source: Medivizor | Added Aug 15, 2021

Oncology Basics 2016: DNA

The Central Dogma of Biology Doesn’t the title above sound imposing? Yet this central idea has moved biological science forward over the last 60 plus years. What we know about cells, genetics and cancer today relies on this "Dogma": DNA carries our hereditary information and transfers that information in a
icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Urology | Added Aug 10, 2021

Is age associated with a poorer outcome for patients undergoing delayed prostate surgery following active surveillance?

This study looked at whether age is related to a risk of poor outcomes in men undergoing delayed radical prostatectomy (RP; prostate removal surgery) following active surveillance (AS). The authors found that older patients require closer monitoring when on AS and may require additional testing to identify the progression of their disease. 

icon
prostate cancer | Medivizor | source: Medivizor | Added Aug 08, 2021

Positive Thinking and Cancer-Myth-Making

Called the "Emperor of All Maladies." there's little doubt that a cancer diagnosis throws life completely out of control.  Unfortunately, this chaos creates vulnerabilities that can and have been exploited.  It is tempting to believe the idea that if you control your thoughts and make them positive, you can control
icon
prostate cancer | Medivizor | source: Medivizor | Added Aug 06, 2021

Oncology Basics 2016: Genes and Cancer Treatment

In Oncology Basics 2016 part 1, we examined the elegance of the cells that make up our body.  In Oncology Basics 2016 part 2, we explored what holds the instructions for life--DNA--and the special processes of self-replication and transcription that are used to pass on and translate those instructions.  Now
icon
prostate cancer | Medivizor | source: Medivizor | Added Aug 04, 2021

Oncology Basics 2016: The Immune System and Immunotherapy

Oncology Basics 2016 continues with a look at the immune system and immunotherapy.  As described in a previous post, one of the regulators of cell division and proliferation is the immune system.  Harnessing the power of the immune system to attack and destroy cancer cells is a promising area of
icon
prostate cancer | Medivizor | source: Medivizor | Added Jul 30, 2021

15 Tips to Cope with Scanxiety (Scan Anxiety)

"Keep Calm And Carry On:" Really? “The shock of that day you hear the words, ‘you have cancer’ never leaves you and your sense of certainty in life and in your body can be hard to recapture after a diagnosis of cancer.”-Marie Ennis-O'Connor After Surgery, Chemo, Radiation This is the
icon
prostate cancer | Medivizor | source: Medivizor | Added Jul 26, 2021

Cancer Patient Resources: Free Air Travel

Cost Medical care for cancer is costly. In addition, there is the financial burden that patients and families face in getting to and from the best care--which may be located at medical centers far from home. The situation can seem overwhelming. Corporate Angel Network Into this dilemma, little known resources
icon
icon
prostate cancer | Research | Treatment | 10 pages | source: International journal of radiation oncology, biology, physics | Added Jul 24, 2021

Evaluating hypofractionated radiotherapy after prostate surgery in patients with prostate cancer.

This study investigated the outcomes of hypofractionated intensity-modulated radiation therapy (H-IMRT) to the prostate bed in patients with localized prostate cancer after prostate surgery. The data showed that H-IMRT after prostate surgery was safe and well-tolerated in these patients.

icon
icon
prostate cancer | Research | Treatment | 10 pages | source: Journal of Urology | Added Jul 20, 2021

Comparing darolutamide with apalutamide and enzalutamide for treating non-metastatic castration-resistant prostate cancer.

The study compared the effectiveness and safety outcomes of darolutamide (Nubeqa) with apalutamide (Erleada) and enzalutamide (Xtandi) in treating non-metastatic castration-resistant prostate cancer (CRPC). The data showed that darolutamide was safer and had similar effectiveness compared to apalutamide and enzalutamide.

View

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?